Changes in plasma levels of ET-1 and its precursor, big ET-1, in the arterial and venous circulation following double myocardial ischemia-reperfusion injury in dogs

Journal of Cardiovascular Pharmacology

Volumn 36, Issue 5 SUPPL. 1, 2000, Pages

  Battistini, B ^a   Kingma J G , Jr ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Arterial; Big ET 1; Coronary; Endothelin (ET); Endothelin converting enzyme activity; Ischemia reperfusion; Ratio; Venous

Indexed keywords

BIG ENDOTHELIN 1; ENDOTHELIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CORONARY SINUS; DOG; ELECTROCARDIOGRAM; FEMALE; HEART HEMODYNAMICS; HEART MUSCLE REPERFUSION; INTERNAL MAMMARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; REPERFUSION INJURY;

EID: 0033751563     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200036001-00047     Document Type: Article

References (28)

1. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
2. A fourth isoform of endothelin-converting enzyme (ECE-1) is generated from an additional promoter molecular cloning and characterization
3. Isoforms of endothelin-converting enzyme: Why and where?
4. Endothelins: Circulating plasma levels and presence in other biologic fluids
5. The many aspects of endothelins in ischemia/reperfusion injury: Emergence of a key mediator
6. Cardiac endothelin and big endothelin in right-heart hypertrophy due to monocrotaline-induced pulmonary hypertension in rat
7. Value of cardiopulmonary exercise testing and big endothelin plasma levels to predict short-term prognosis of patients with chronic heart failure
8. Direct enzyme immunometric measurement of plasma big endothelin-I concentrations and correlation with indicators of left ventricular function
9. Myocardial blood flow regulation relative to left ventricle pressure and volume in anesthetized dogs
10. Endothelin in experimental congestive heart failure in anesthetized dog
11. Elevation of plasma ET concentrations during endotoxin shock in dogs
12. Increased plasma levels of ET with vasoconstriction after dextran infusion
13. Plasma endothelin levels during myocardial ischemia and reperfusion
14. Endothelin has biological actions at physiological concentrations
15. Cardiovascular and endocrine effects of ET-1 at pathophysiological and pharmacological plasma concentrations in conscious dogs
16. Increased endothelin in experimental heart failure
17. Concentrations and ratios of immunoreactive big-endothelin-1 and endothelin-1 in human, rat and rabbit plasma
18. Reperfusion enhances the local release of endothelin after regional myocardial ischemia
19. Cardiac endothelin release and infarct size, myocardial blood flow, and ventricular function in canine infarction and reperfusion
20. Intravenous administration of the endothelin-1 antagonist BQ-123 does not ameliorate myocardial ischaemic injury following acute coronary artery occlusion in the dog
21. Endothelin-1 and unstable angina: Effect of either endothelin ET(A) or ET(B) receptor antagonism in a locally injured canine coronary artery
22. Role of endogenous endothelin in the extension of myocardial infarct size studied with the endothelin receptor antagonist, TAK-044
23. Effects of low doses of endothelin-1 on basal vascular tone and autoregulatory vasodilation in canine coronary microcirculation in vivo
24. Endothelin concentration in plasma of healthy dogs and dogs with congestive heart failure, renal failure, diabetes mellitus, and hyperadrenocorticism
25. Plasma endothelin in normal and diabetic pregnancy
26. Endothelial dysfunction in human disease
27. Receptor- and non-receptor-mediated clearance of big-endothelin and endothelin-1: Differential effects of acute and chronic ETA receptor blockade
28. Metabolism of big endothelin-1 (1-38) and (22-38) in the human circulation in relation to production of endothelin-1 (1-21)